Researchers from Yale have developed a way to monitor engineered blood vessels that have been implanted in recipient patients. Using a combination of magnetic resonance imaging and nanoparticle technology, they are now able to monitor the growth and progress of the implanted tissue, which was not possible before. These engineered tissues are made with a patient's own biological material, and are sometimes used to treat conditions like congenital heart defects. The new monitoring procedure was successful in trials with mice.
No comments:
Post a Comment